Safety of Continuous Neostigmine for the Treatment of Impaired Gastrointestinal Motility in Pediatric Patients

Ann Pharmacother. 2021 Feb;55(2):267-268. doi: 10.1177/1060028020940622. Epub 2020 Jul 4.
No abstract available

Publication types

  • Letter